Few Discontinuation Symptoms Reported After Stopping Antidepressants
By Elana Gotkine HealthDay Reporter
THURSDAY, July 17, 2025 -- Most individuals do not go through severe withdrawal after discontinuing antidepressants, according to a study published online July 9 in JAMA Psychiatry.
Michail Kalfas, from King's College London, and colleagues conducted a systematic review and meta-analysis to examine the presence of discontinuation symptoms using standardized scales (e.g., Discontinuation-Emergent Signs and Symptoms [DESS]) and the incidence of individual discontinuation symptoms in a review of randomized clinical trials involving individuals who stop taking antidepressants. Fifty studies with 17,828 individuals were reviewed, and 49 studies were included in meta-analyses.
The researchers found that the DESS meta-analysis indicated increased discontinuation symptoms at one week in participants stopping antidepressants versus those taking placebo or continuing antidepressants (standardized mean difference, 0.31), with an effect size equivalent to one more symptom on the DESS. Increased odds of dizziness, nausea, vertigo, and nervousness were seen with discontinuation of antidepressants compared with placebo discontinuation. The most prevalent symptom of discontinuation was dizziness (risk difference, 6.24 percent). Despite being measured in people with major depressive disorder, discontinuation was not associated with depression symptoms.
"Despite previous concern about stopping antidepressants, our work finds that most people do not experience severe withdrawal, in terms of additional symptoms. Importantly, depression relapse was not linked to antidepressant withdrawal in these studies," senior author Sameer Jauhar, Ph.D., also from King’s College London, said in a statement.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Loneliness Is Predictor of Depression, Poor Health Outcomes
THURSDAY, July 10, 2025 -- Loneliness is a predictor of depression and poor health outcomes, according to a study published online July 9 in PLOS ONE. Oluwasegun Akinyemi, M.D...
Preschool Depression Intervention Has Long-Term Beneficial Effects
THURSDAY, July 10, 2025 -- Completion of a Parent–Child Interaction Therapy-Emotion Development (PCIT-ED) intervention for preschool depression has long-term effects and is...
Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers
WEDNESDAY, July 9, 2025 -- Sleep disorders such as obstructive sleep apnea (OSA) contribute to mental health challenges, traumatic injuries, and increased health care utilization...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.